Markers of cardio-vascular remodeling in hypertension

被引:0
作者
Legedz, L
Rial, MO
Lantelme, P
Champomier, P
Cerutti, C
Vincent, M
Bricca, G
Milon, H
机构
[1] Hop Croix Rousse, Serv Cardiol, F-69317 Lyon, France
[2] INSERM, U331, Fac Med Laennec, Lyon, France
[3] Fac Med, Lab Explorat Fonct Endocriniennes & Metab, Lyon, France
来源
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 2003年 / 96卷 / 7-8期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our goal was to study the relative infuence of systolic blood pressure (SBP) and plasmatic markers of sympathetic and renin-aldosterone systems (PLAS) activities to left atrial diameter (LAD), left ventricular posterior wall thickness (LVPWT) and pulse wave velocity (PWV), which reflect cardiovascular remodeling in hypertension. Methods: in 227 consecutive patients with hypertension (mean age+/-SD: 53.3 years+/-13.4, 126 men), we measured: PWV, LAD, LVPWT, mean 24-hours SBP, plasma renin activity, and plasma aldosterone and catecholamine levels. Multiples linear regression analyses were performed to test statistical associations between hemodynamic and neurohumoral factors, and cardiovascular remodeling parameters, after adjustement for age, gender and body mass index. Results: LVPWT was positively correlated to SBP as well as to plasma aldosterone and meta-noradrenaline (p<0.001). LAD and PWV were related to SBP but not to any of the biological variables. Moreover, LAD correlated to PWV independently of SBP (p<0.05), whereas after SBP inclusion in the model, there was not significant correlation between LAD and LVPWT nor between LVPWT and PWV. Conclusion: in hypertension, the development of cardiac hypertrophy depends on SBP and the sympathetic and renin-aldosterone systems activities. The RAS is not involved in the PWV nor LAD modifications. Strong association between LAD and PWV suggest that left atrial enlargement, that may be considered as a marker of diastolic function, may results more from arterial stiffness than from ventricular hypertrophy.
引用
收藏
页码:729 / 733
页数:5
相关论文
共 10 条
[1]   Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy -: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study [J].
Gerdts, E ;
Oikarinen, L ;
Palmieri, V ;
Otterstad, JE ;
Wachtell, K ;
Boman, K ;
Dahlöf, B ;
Devereux, RB .
HYPERTENSION, 2002, 39 (03) :739-743
[2]   Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension [J].
Goldkorn, R ;
Yurenev, A ;
Blumenfeld, J ;
Fishman, D ;
Devereux, RB .
AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (04) :340-345
[3]  
GUARINI P, 1994, INT ANGIOL, V13, P317
[4]   MEASUREMENT OF PLASMA METHOXYAMINES FOR THE DIAGNOSIS OF PHEOCHROMOCYTOMA [J].
MORNEX, R ;
PEYRIN, L ;
PAGLIARI, R ;
COTTETEMARD, JM .
HORMONE RESEARCH, 1991, 36 (5-6) :220-226
[5]   Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy [J].
Olsen, MH ;
Wachtell, K ;
Hermann, KL ;
Frandsen, E ;
Dige-Petersen, H ;
Rokkedal, J ;
Devereux, RB ;
Ibsen, H .
AMERICAN HEART JOURNAL, 2002, 144 (03) :530-537
[6]   PARALLEL CARDIAC AND VASCULAR ADAPTATION IN HYPERTENSION [J].
ROMAN, MJ ;
SABA, PS ;
PINI, R ;
SPITZER, M ;
PICKERING, TG ;
ROSEN, S ;
ALDERMAN, MH ;
DEVEREUX, RB .
CIRCULATION, 1992, 86 (06) :1909-1918
[7]   Changes in left ventricular anatomy and function in hypertension and primary aldosteronism [J].
Rossi, GP ;
Sacchetto, A ;
Visentin, P ;
Canali, C ;
Graniero, GR ;
Palatini, P ;
Pessina, AC .
HYPERTENSION, 1996, 27 (05) :1039-1045
[8]   Mitral flow derived Doppler indices of left ventricular diastolic function in a general population - The Tromso study [J].
Schirmer, H ;
Lunde, P ;
Rasmussen, K .
EUROPEAN HEART JOURNAL, 2000, 21 (16) :1376-1386
[9]   Left atrial size in 164 hypertensive patients: An echocardiographic and ambulatory blood pressure study [J].
Tedesco, MA ;
Di Salvo, G ;
Ratti, G ;
Natale, F ;
Iarussi, D ;
Iacono, A .
CLINICAL CARDIOLOGY, 2001, 24 (09) :603-607
[10]   Norepinephrine and concentric hypertrophy in patients with end-stage renal disease [J].
Zoccali, C ;
Mallamaci, F ;
Tripepi, G ;
Parlongo, S ;
Cutrupi, S ;
Benedetto, FA ;
Cataliotti, A ;
Malatino, LS .
HYPERTENSION, 2002, 40 (01) :41-46